Complete Filing Data
Fast Track Group reported Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations of $268.4 thousand for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Fast Track Group did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue From Contract With Customer Excluding Assessed Tax | $751.1K | $1.3M | $48.0K |
| Operating Lease Impairment Loss | $40.5K | $21.0K | $2.0K |
| Operating Income Loss | -$426.9K | $33.5K | $30.5K |
| Operating Expenses | $411.7K | $231.9K | $13.6K |
| Net Income Loss | -$335.3K | $33.3K | $29.9K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$452.5K | $33.3K | $29.9K |
| Gross Profit | $95.3K | $265.4K | $44.1K |
| General And Administrative Expense | $381.6K | $210.9K | $11.6K |
| Cost Of Revenue | $884.9K | $1.0M | $3.9K |
| Other Nonoperating Income | $650.00 | $267.00 | $102.00 |
| Interest Expense | $19.6K | $468.00 | $723.00 |
| Deferred Revenue Current | $544.7K | $16.7K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $268.4K | $2.4K | $52.1K | $2.2K |
| Stockholders Equity | -$1.2M | -$753.1K | -$1.8M | -$1.8M |
| Retained Earnings Accumulated Deficit | -$2.3M | -$1.9M | ||
| Operating Lease Right Of Use Asset | $17.2K | $61.4K | ||
| Operating Lease Liability Current | $20.5K | $38.2K | ||
| Liabilities Current | $2.3M | $860.1K | ||
| Liabilities And Stockholders Equity | $1.4M | $133.8K | ||
| Liabilities | $2.6M | $886.9K | ||
| Common Stock Value | $23.6K | $23.6K | ||
| Cash And Cash Equivalents At Carrying Value | $268.4K | $3.2K | ||
| Assets Noncurrent | $25.3K | $61.4K | ||
| Assets Current | $987.5K | $72.4K | ||
| Assets | $1.0M | $133.8K | ||
| Accrued Liabilities Current | $585.0K | $25.3K | ||
| Accounts Receivable Net Current | $113.6K | $61.8K | ||
| Accounts Payable Current | $325.1K | $438.7K | ||
| Property Plant And Equipment Net | $2.0K | |||
| Operating Lease Liability Noncurrent | $2.1K | $23.3K | ||
| Loans Payable Current | $3.4K | $10.4K | ||
| Liabilities Noncurrent | $279.0K | $26.8K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $265.2K | -$48.9K | $49.9K | |
| Warrant Liabilities | $204.7K | |||
| Repayments Of Deferred Offering Costs | $584.0K | |||
| Other Assets Current | $15.3K | $7.4K | ||
| Deferred Offering Costs | $788.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | $317.5K | -$9.5K | $36.5K |
| Net Cash Provided By Used In Financing Activities | -$161.0K | -$39.4K | $13.4K |
| Increase Decrease In Other Current Assets | $5.9K | $7.4K | -$77.00 |
| Increase Decrease In Accrued Liabilities | $559.7K | $9.6K | $6.5K |
| Proceeds From Lines Of Credit | $276.3K | ||
| Payments To Acquire Property Plant And Equipment | $2.2K | ||
| Net Cash Provided By Used In Investing Activities | -$1.6K | ||
| Increase Decrease In Deferred Revenue | $528.0K | $16.7K | |
| Increase Decrease In Advance Payment To Vendor | $109.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Earnings Per Share Diluted | $-0.02 | $0.00 | $0.00 |
| Earnings Per Share Basic | $-0.03 | $0.00 | $0.00 |
| Common Stock Shares Outstanding | 17.5M | 17.5M | |
| Common Stock Shares Issued | 17.5M | 17.5M | |
| Common Stock Shares Authorized | 50.0M | 50.0M | |
| Weighted Average Number Of Shares Outstanding Basic | 17.5M | 17.5M | 17.5M |
| Weighted Average Number Of Diluted Shares Outstanding | 17.5M | 17.5M | 17.5M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Repayments Of Lines Of Credit | $10.5K | $10.2K | $9.9K |
| Interest Paid Net | $110.00 | $468.00 | $723.00 |
| Provision For Doubtful Accounts | $33.4K | $97.2K | |
| Net Movements In Amount Due To Director | -$361.2K | $29.2K | -$23.3K |
| Additional Paid In Capital | $797.7K | $1.1M | |
| Depreciation Nonproduction | $137.00 | ||
| Depreciation | $185.00 |
Most recent annual filing with the SEC: July 14, 2025
Data sourced from SEC EDGAR public filings as of August 5, 2026.